{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:03:47Z","timestamp":1792091027114,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41401-019-0342-5","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T09:03:00Z","timestamp":1578992580000},"page":"866-878","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Mechanisms and pharmacokinetic\/pharmacodynamic profiles underlying the low nephrotoxicity and ototoxicity of etimicin"],"prefix":"10.1038","volume":"41","author":[{"given":"Lan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-min","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-guo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-wen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-ji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"342_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1021\/cb3005116","volume":"8","author":"B Becker","year":"2013","unstructured":"Becker B, Cooper MA. Aminoglycoside antibiotics in the 21st century. ACS Chem Biol 2013;8:105\u201315.","journal-title":"ACS Chem Biol"},{"key":"342_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/QCO.0000000000000012","volume":"26","author":"J Jackson","year":"2013","unstructured":"Jackson J, Chen C, Buising K. Aminoglycosides: how should we use them in the 21st century? Curr Opin Infect Dis 2013;26:516\u201325.","journal-title":"Curr Opin Infect Dis"},{"key":"342_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ccc.2010.11.006","volume":"27","author":"WA Craig","year":"2011","unstructured":"Craig WA. Optimizing aminoglycoside use. Crit Care Clin 2011;27:107\u201321.","journal-title":"Crit Care Clin"},{"key":"342_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","volume":"13","author":"MS Ramirez","year":"2010","unstructured":"Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Updates 2010;13:151\u201371.","journal-title":"Drug Resist Updates"},{"key":"342_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1128\/AAC.3.4.445","volume":"3","author":"VK Simon","year":"1973","unstructured":"Simon VK, Mosinger EU, Malerczy V. Pharmacokinetic studies of tobramycin and gentamicin. Antimicrob Agents Chemother 1973;3:445\u201350.","journal-title":"Antimicrob Agents Chemother"},{"key":"342_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/jat\/28.3.187","volume":"28","author":"DN Bailey","year":"2004","unstructured":"Bailey DN, Briggs JR. Gentamicin and tobramycin binding to human serum in vitro. J Anal Toxicol 2004;28:187\u20139.","journal-title":"J Anal Toxicol"},{"key":"342_CR7","doi-asserted-by":"publisher","first-page":"S316","DOI":"10.1093\/infdis\/135.Supplement_2.S316","volume":"134","author":"H Lode","year":"1976","unstructured":"Lode H, Grunert K, Koeppe P, Langmaack H. Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic. J Infect Dis 1976;134:S316\u201322.","journal-title":"J Infect Dis"},{"key":"342_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1568005043340858","volume":"4","author":"F Rougier","year":"2004","unstructured":"Rougier F, Claude D, Maurin M, Maire P. Aminoglycoside nephrotoxicity. Curr Drug Targets Infect Disord 2004;4:153\u201362.","journal-title":"Curr Drug Targets Infect Disord"},{"key":"342_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tox.2008.04.015","volume":"249","author":"OW Guthrie","year":"2008","unstructured":"Guthrie OW. Aminoglycoside induced ototoxicity. Toxicology 2008;249:91\u20136.","journal-title":"Toxicology"},{"key":"342_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.taap.2007.05.004","volume":"223","author":"SC Martinez","year":"2007","unstructured":"Martinez SC, Lopez FJ, Lopez JM. Glomerular nephrotoxicity of aminoglycosides. Toxicol Appl Pharmacol 2007;223:86\u201398.","journal-title":"Toxicol Appl Pharmacol"},{"key":"342_CR11","first-page":"1026","volume":"113","author":"C Zhao","year":"2000","unstructured":"Zhao C, Li J, Hou J, Guo M, Zhang Y, Chen Y. A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections. Chin Med J 2000;113:1026\u201330.","journal-title":"Chin Med J"},{"key":"342_CR12","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1007\/s11274-012-1148-5","volume":"28","author":"M Chaudhary","year":"2012","unstructured":"Chaudhary M, Kesava NG, Kumar S, Payasi A. Comparative antibacterial activity of a novel semisynthetic antibiotic: etimicin sulphate and other aminoglycosides. World J Microbiol Biotechnol 2012;28:3365\u201371.","journal-title":"World J Microbiol Biotechnol"},{"key":"342_CR13","first-page":"83","volume":"23","author":"TC Lan","year":"2004","unstructured":"Lan TC, Lin HJ, Ping YH, Ming LJ. Comparison of clinical efficacy and safety between etimicin and netilmicin in treatment of bacterial infections in lower respiratory tract. Chin J New Drugs Clin Rem 2004;23:83\u20137.","journal-title":"Chin J New Drugs Clin Rem"},{"key":"342_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2131\/jts.35.479","volume":"35","author":"A Payasi","year":"2010","unstructured":"Payasi A, Chaudhary M, Gupta A, Dwivedi VK. Sub-acute toxicity study of a new aminoglycoside etimicin sulphate in swiss albino mice. J Toxicol Sci 2010;35:479\u201384.","journal-title":"J Toxicol Sci"},{"key":"342_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jpba.2017.08.027","volume":"146","author":"L Yao","year":"2017","unstructured":"Yao L, Zhou F, Cai M, Peng Y, Sun J, Chen Q, et al. Development and validation of a sensitive LC-MS\/MS method without derivatization\/ion-pairing agents for etimicin quantification in rat plasma, internal ear and kidney. J Pharm Biomed Anal 2017;146:96\u2013102.","journal-title":"J Pharm Biomed Anal"},{"key":"342_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000071059","volume":"8","author":"GM Kalinec","year":"2003","unstructured":"Kalinec GM, Webster P, Lim DJ, Kalinec F. A cochlear cell line as an in vitro system for drug ototoxicity screening. Audio Neurootol 2003;8:177\u201389.","journal-title":"Audio Neurootol"},{"key":"342_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1476-5381.2011.01505.x","volume":"165","author":"J Zhang","year":"2012","unstructured":"Zhang J, Zhou F, Wu X, Zhang X, Chen Y, Zha BS, et al. Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7\/Adr cells. Br J Pharmacol 2012;165:120\u201334.","journal-title":"Br J Pharmacol"},{"key":"342_CR18","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1002\/jcp.24941","volume":"230","author":"R Yue","year":"2015","unstructured":"Yue R, Xia X, Jiang J, Yang D, Han Y, Chen X, et al. Mitochondrial DNA oxidative damage contributes to cardiomyocyte ischemia\/reperfusion-injury in rats: cardioprotective role of lycopene. J Cell Physiol 2015;230:2128\u201341.","journal-title":"J Cell Physiol"},{"key":"342_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/path.2175","volume":"212","author":"MM Timmeren","year":"2007","unstructured":"Timmeren MM, Heuvel MC, Bailly V, Bakker SJ, Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 2007;212:209\u201317.","journal-title":"J Pathol"},{"key":"342_CR20","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2174\/1389203717666160909125004","volume":"18","author":"W Shang","year":"2017","unstructured":"Shang W, Wang Z. The update of NGAL in acute kidney injury. Curr Protein Pept Sci 2017;18:1211\u20137.","journal-title":"Curr Protein Pept Sci"},{"key":"342_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF00457444","volume":"232","author":"CS Chen","year":"1981","unstructured":"Chen CS, Aberdeen GC. The sensitive period for induction of susceptibility to audiogenic seizures by kanamycin in mice. Arch Otorhinolaryngol 1981;232:215\u201320.","journal-title":"Arch Otorhinolaryngol"},{"key":"342_CR22","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.tiv.2007.01.011","volume":"21","author":"S Nadanaciva","year":"2007","unstructured":"Nadanaciva S, Bernal A, Aggeler R, Capaldi R, Will Y. Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays. Toxicol In vitro 2007;21:902\u201311.","journal-title":"Toxicol In vitro"},{"key":"342_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.taap.2007.06.003","volume":"223","author":"S Nadanaciva","year":"2007","unstructured":"Nadanaciva S, Dykens JA, Bernal A, Capaldi RA, Will Y. Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration. Toxicol Appl Pharmacol 2007;223:277\u201387.","journal-title":"Toxicol Appl Pharmacol"},{"key":"342_CR24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1152\/physrev.00025.2007","volume":"88","author":"RC Scarpulla","year":"2008","unstructured":"Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008;88:611\u201338.","journal-title":"Physiol Rev"},{"key":"342_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1128\/AAC.12.2.178","volume":"12","author":"EF Christensen","year":"1977","unstructured":"Christensen EF, Reiffenstein JC, Madissoo H. Comparative ototoxicity of amikacin and gentamicin in cats. Antimicrob Agents Chemother 1977;12:178\u201384.","journal-title":"Antimicrob Agents Chemother"},{"key":"342_CR26","first-page":"795","volume":"36","author":"B Olier","year":"1988","unstructured":"Olier B, Morin JP, Thomas N, Fillastre JP. Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin. Pathol Biol 1988;36:795\u2013800.","journal-title":"Pathol Biol"},{"key":"342_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0272-0590(92)90108-T","volume":"18","author":"M Yamamoto","year":"1992","unstructured":"Yamamoto M, Kurata Y, Chiba S. Effects of aminoglycoside antibiotics on the auditory brainstem response and post rotatory nystagmus in rats. Fundam Appl Toxicol 1992;18:499\u2013503.","journal-title":"Fundam Appl Toxicol"},{"key":"342_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ki.2010.337","volume":"79","author":"JM Lopez","year":"2011","unstructured":"Lopez JM, Quiros Y, Vicente L, Morales AI, Lopez FJ. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 2011;79:33\u201345.","journal-title":"Kidney Int"},{"key":"342_CR29","doi-asserted-by":"publisher","unstructured":"Jiang M, Karasawa T, Steyger PS. Aminoglycoside-induced cochleotoxicity: a review. Front Cell Neurosci 2017;11:308.\u00a0https:\/\/doi.org\/10.3389\/fncel.2017.00308.","DOI":"10.3389\/fncel.2017.00308"},{"key":"342_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/00016487809124715","volume":"86","author":"Y Toyoda","year":"1978","unstructured":"Toyoda Y, Tachibana M. Tissue levels of kanamycin in correlation with oto- and nephrotoxicity. Acta Otolaryngol 1978;86:9\u201314.","journal-title":"Acta Otolaryngol"},{"key":"342_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10162-003-4002-5","volume":"4","author":"PS Steyger","year":"2003","unstructured":"Steyger PS, Peters SL, Rehling J, Hordichok A, Dai CF. Uptake of gentamicin by bullfrog saccular hair cells in vitro. J Assoc Res Otolaryngol 2003;4:565\u201378.","journal-title":"J Assoc Res Otolaryngol"},{"key":"342_CR32","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1128\/AAC.35.11.2173","volume":"35","author":"D Beauchamp","year":"1991","unstructured":"Beauchamp D, Gourde P, Bergeron MG. Subcellular distribution of gentamicin in proximal tubular cells, determined by immunogold labeling. Antimicrob Agents Chemother 1991;35:2173\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"342_CR33","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1126\/science.283.5407.1476","volume":"283","author":"MW Gray","year":"1999","unstructured":"Gray MW, Burger G, Lang BF. Mitochondrial evolution. Science 1999;283:1476\u201381.","journal-title":"Science"},{"key":"342_CR34","doi-asserted-by":"publisher","first-page":"886","DOI":"10.2119\/molmed.2015.00196","volume":"21","author":"CH Chen","year":"2016","unstructured":"Chen CH, Chen TH, Wu MY, Chen JR, Hong LY, Zheng CM, et al. Peroxisome proliferator-activated receptor alpha protects renal tubular cells from gentamicin-induced apoptosis via upregulating Na+\/H+ exchanger NHE1. Mol Med 2016;21:886\u20139.","journal-title":"Mol Med"},{"key":"342_CR35","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","volume":"120","author":"RS Balaban","year":"2005","unstructured":"Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2005;120:483\u201395.","journal-title":"Cell"},{"key":"342_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0736-5748(99)00094-5","volume":"18","author":"T Huang","year":"2000","unstructured":"Huang T, Cheng AG, Stupak H, Liu W, Kim A, Staecker H, et al. Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies. Int J Dev Neurosci 2000;18:259\u201370.","journal-title":"Int J Dev Neurosci"},{"key":"342_CR37","first-page":"666","volume":"77","author":"SS Jankauskas","year":"2012","unstructured":"Jankauskas SS, Plotnikov EY, Morosanova MA, Pevzner IB, Zorova LD, Skulachev VP, et al. Mitochondria-targeted antioxidant SkQR1 ameliorates gentamycin-induced renal failure and hearing loss. Biochemistry 2012;77:666\u201370.","journal-title":"Biochemistry"},{"key":"342_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.tiv.2006.09.004","volume":"21","author":"WP Mao","year":"2007","unstructured":"Mao WP, Ye JL, Guan ZB, Zhao JM, Zhang C, Zhang NN, et al. Cadmium induces apoptosis in human embryonic kidney (HEK) 293 cells by caspase-dependent and caspase-independent pathways acting on mitochondria. Toxicol In vitro 2007;21:343\u201354.","journal-title":"Toxicol In vitro"},{"key":"342_CR39","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2337\/db13-1412","volume":"63","author":"L Xiao","year":"2014","unstructured":"Xiao L, Zhu X, Yang S, Liu F, Zhou Z, Zhan M, et al. Rap1 ameliorates renal tubular injury in diabetic nephropathy. Diabetes 2014;63:1366\u201380.","journal-title":"Diabetes"},{"key":"342_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.toxlet.2016.01.005","volume":"245","author":"YR Kim","year":"2016","unstructured":"Kim YR, Kim MA, Cho HJ, Oh SK, Lee IK, Kim UK, et al. Galangin prevents aminoglycoside-induced ototoxicity by decreasing mitochondrial production of reactive oxygen species in mouse cochlear cultures. Toxicol Lett 2016;245:78\u201385.","journal-title":"Toxicol Lett"},{"key":"342_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000096860","volume":"105","author":"AM Hall","year":"2007","unstructured":"Hall AM, Unwin RJ. The not so \u2018mighty chondrion': emergence of renal diseases due to mitochondrial dysfunction. Nephron Physiol 2007;105:1\u201310.","journal-title":"Nephron Physiol"},{"key":"342_CR42","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.cell.2015.10.070","volume":"163","author":"HC Wang","year":"2015","unstructured":"Wang HC, Lin CC, Cheung R, Zhang-Hooks Y, Agarwal A, Ellis-Davies G, et al. Spontaneous activity of cochlear hair cells triggered by fluid secretion mechanism in adjacent support cells. Cell 2015;163:1348\u201359.","journal-title":"Cell"},{"key":"342_CR43","first-page":"F315","volume":"274","author":"W Lieberthal","year":"1998","unstructured":"Lieberthal W, Menza SA, Levine JS. Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol 1998;274:F315\u201327.","journal-title":"Am J Physiol"},{"key":"342_CR44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cellsig.2014.11.024","volume":"27","author":"K Hayashi","year":"2015","unstructured":"Hayashi K, Dan K, Goto F, Tshuchihashi N, Nomura Y, Fujioka M, et al. The autophagy pathway maintained signaling crosstalk with the Keap1-Nrf2 system through p62 in auditory cells under oxidative stress. Cell Signal 2015;27:382\u201393.","journal-title":"Cell Signal"},{"key":"342_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev.physiol.010908.163119","volume":"71","author":"MB Hock","year":"2009","unstructured":"Hock MB, Kralli A. Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol 2009;71:177\u2013203.","journal-title":"Annu Rev Physiol"},{"key":"342_CR46","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1016\/j.diabres.2007.01.052","volume":"77","author":"YM Cho","year":"2007","unstructured":"Cho YM, Park KS, Lee HK. Genetic factors related to mitochondrial function and risk of diabetes mellitus. Diabetes Res Clin Pract 2007;77:S172\u20137.","journal-title":"Diabetes Res Clin Pract"},{"key":"342_CR47","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ebiom.2015.04.002","volume":"2","author":"A Czajka","year":"2015","unstructured":"Czajka A, Ajaz S, Gnudi L, Parsade CK, Jones P, Reid F, et al. Altered mitochondrial function, mitochondrial DNA and reduced metabolic flexibility in patients with diabetic nephropathy. EBioMedicine 2015;2:499\u2013512.","journal-title":"EBioMedicine"},{"key":"342_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10522-013-9475-y","volume":"15","author":"H Chen","year":"2014","unstructured":"Chen H, Tang J. The role of mitochondria in age-related hearing loss. Biogerontology 2014;15:13\u20139.","journal-title":"Biogerontology"},{"key":"342_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999;98:115\u201324.","journal-title":"Cell"},{"key":"342_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-4781(02)00343-3","volume":"1576","author":"RC Scarpulla","year":"2002","unstructured":"Scarpulla RC. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 2002;1576:1\u201314.","journal-title":"Biochim Biophys Acta"},{"key":"342_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1124\/jpet.114.214700","volume":"350","author":"SM Garrett","year":"2014","unstructured":"Garrett SM, Whitaker RM, Beeson CC, Schnellmann RG. Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injury. J Pharmacol Exp Ther. 2014;350:257\u201364.","journal-title":"J Pharmacol Exp Ther"},{"key":"342_CR52","doi-asserted-by":"publisher","first-page":"F1410","DOI":"10.1152\/ajprenal.00622.2013","volume":"306","author":"C Zhu","year":"2014","unstructured":"Zhu C, Xuan X, Che R, Ding G, Zhao M, Bai M, et al. Dysfunction of the PGC-1alpha-mitochondria axis confers adriamycin-induced podocyte injury. Am J Physiol Ren Physiol 2014;306:F1410\u20137.","journal-title":"Am J Physiol Ren Physiol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0342-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0342-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0342-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:40Z","timestamp":1684616560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0342-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["342"],"URL":"https:\/\/doi.org\/10.1038\/s41401-019-0342-5","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"17 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}